scholarly journals Design and development of a nanoemulsion system containing extract of Clinacanthus nutans (L.) leaves for transdermal delivery system by D-optimal mixture design and evaluation of its physicochemical properties

RSC Advances ◽  
2016 ◽  
Vol 6 (71) ◽  
pp. 67378-67388 ◽  
Author(s):  
Intan Soraya Che Sulaiman ◽  
Mahiran Basri ◽  
Hamid Reza Fard Masoumi ◽  
Siti Efliza Ashari ◽  
Maznah Ismail

C. nutansis a well-known medicinal plant in South-East Asia that has attracted attention for its therapeutic characteristics. In this work, nanoemulsion has been chosen to be a carrier in encapsulation ofC. nutansextract for its potential in nanotechnology application.

2018 ◽  
Vol 192 ◽  
pp. 01008
Author(s):  
Worranan Rangsimawong ◽  
Paisit Wattanasri ◽  
Prasert Akkaramongkolporn ◽  
Prasopchai Tonglairoum ◽  
Tanasait Ngawhirunpat ◽  
...  

Kaempferia parviflora (KP) extract has been used in the Thai medicinal plant recipe, which the methoxyflavones are the main active compound. These compounds have low water solubility, high lipophilicity, and low bioavailability. The aim of this study was to develop the pluronic lecithin organogel (PLO) and PLO with d-limonene (PLO-L) for enhancing transdermal delivery of KP extract. These formulations were prepared and their physicochemical properties, stability, and in vitro skin permeation were evaluated. For the result, all formulations exhibited good physicochemical properties and stable under storage condition for 3 months. The permeation of KP extract-loaded PLO-L and PLO formulation showed significantly higher total methoxyflavones permeated through the skin than KP extract in water, which PLO-L provided the highest permeated flux of total methoxyflavones. This result suggested that d-limonene play a role as skin permeation enhancer. Organogel consisting of poloxamer 407 and lecithin also increased the skin permeation of KP extract. In conclusion, PLO-L could be a potential transdermal delivery system for KP extract.


2010 ◽  
Vol 399 (1-2) ◽  
pp. 87-93 ◽  
Author(s):  
Yasuko Obata ◽  
Yuriko Ashitaka ◽  
Shingo Kikuchi ◽  
Koichi Isowa ◽  
Kozo Takayama

2011 ◽  
Vol 9 (6) ◽  
Author(s):  
Ashish A Heda ◽  
Aravind R Sonawane ◽  
Gautam H Naranje ◽  
Vijay G Somani ◽  
Prashant K Puranik

2021 ◽  
Vol 27 ◽  
Author(s):  
Sana Kalave ◽  
Bappaditya Chatterjee ◽  
Parth Shah ◽  
Ambikanandan Misra

: Skin being the largest external organ, offers an enticing procedure for transdermal drug delivery, so the drug needs to rise above the outermost layer of the skin, i.e., stratum corneum. Small molecular drug entities obeying the Lipinski rule, i.e., drugs having a molecular weight less than 500Da, high lipophilicity, and optimum polarity, are favored enough to be used on the skin as therapeutics. Skin's barrier action properties prevent the transport of macromolecules at pre-determined therapeutic rates. Notable advancement in macromolecules' transdermal delivery occurred in recent years. Scientists have opted for liposomes, the use of electroporation or, low-frequency ultrasound techniques. Some of these have shown better delivery of macromolecules at clinically beneficial rates. These physical technologies involve complex mechanisms, which may irreversibly incur skin damage. Majorly, two types of lipid-based formulations, including Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) are widely investigated as a transdermal delivery system. In this review, the concepts, mechanisms, and applications of Nanostructured Lipid Carriers that are considered feasible for transporting macromolecules via transdermal delivery system are thoroughly reviewed and presented along with their clinical perspective.


Sign in / Sign up

Export Citation Format

Share Document